AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
PHENYLEPHRINE
5 registrations across 4 African markets— 1 active
Markets with PHENYLEPHRINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PHENYLEPHRINE COVAN | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Sept 2025 |
| PHENYLEPHRINE AGUETTANT 50 ?G/ML SOLUTION INJECTABLE BOITE DE 10 | 🇨🇮Côte d'Ivoire | FRILAB SA | expired | Feb 2024 |
| FENOX NASAL SPRAY | 🇿🇦South Africa | BOOTS PHARMACEUTICALS (PTY) LTD | suspended | Apr 2022 |
| NEOPHRINE Collyre / 10% | 🇹🇳Tunisia | UNIMED | expired | Aug 2007 |
| PHENYLEPHRINE AGUETTANT injectable / 50 mcg / ml | 🇸🇳Senegal | AGUETTANT | active | — |
PHENYLEPHRINE in Africa — Regulatory Overview
PHENYLEPHRINE is registered across 4 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Côte d'Ivoire, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 1 (20%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.